Target Score—A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness
Open Access
- 7 February 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (4), 1664
- https://doi.org/10.3390/ijms22041664
Abstract
Esophageal cancer (EC) is a life-threatening disease, demanding the discovery of new biomarkers and molecular targets for precision oncology. Aberrantly glycosylated proteins hold tremendous potential towards this objective. In the current study, a series of esophageal squamous cell carcinomas (ESCC) and EC-derived circulating tumor cells (CTCs) were screened by immunoassays for the sialyl-Tn (STn) antigen, a glycan rarely expressed in healthy tissues and widely observed in aggressive gastrointestinal cancers. An ESCC cell model was glycoengineered to express STn and characterized in relation to cell proliferation and invasion in vitro. STn was found to be widely present in ESCC (70% of tumors) and in CTCs in 20% of patients, being associated with general recurrence and reduced survival. Furthermore, STn expression in ESCC cells increased invasion in vitro, while reducing cancer cells proliferation. In parallel, an ESCC mass spectrometry-based proteomics dataset, obtained from the PRIDE database, was comprehensively interrogated for abnormally glycosylated proteins. Data integration with the Target Score, an algorithm developed in-house, pinpointed the glucose transporter type 1 (GLUT1) as a biomarker of poor prognosis. GLUT1-STn glycoproteoforms were latter identified in tumor tissues in patients facing worst prognosis. Furthermore, healthy human tissues analysis suggested that STn glycosylation provided cancer specificity to GLUT1. In conclusion, STn is a biomarker of worst prognosis in EC and GLUT1-STn glycoforms may be used to increase its specificity on the stratification and targeting of aggressive ESCC forms.Funding Information
- Fundação para a Ciência e a Tecnologia (SFRH/BD/111242/2015, SFRH/BD/146500/2019, SFRH/BD/142479/2018, SFRH/BD/105355/2014, CEECIND/03186/2017, PEst-OE/SAU/UI0776/201, UIDB/50006/2020, DSAIPA/DS/0042/2018)
- Instituto Português de Oncologia do Porto (CI-IPOP-29-2020, CI-IPOP-58-2020, CI-IPOP-Proj.70-bolsa2019-GPTE)
- European Regional Development Fund (NORTE-01-0145-FEDER-000027)
This publication has 56 references indexed in Scilit:
- Byonic: Advanced Peptide and Protein Identification SoftwareCurrent Protocols in Bioinformatics, 2012
- Sialyl-Tn in Cancer: (How) Did We Miss the Target?Biomolecules, 2012
- Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progressionGut, 2011
- Clinical significance of GLUT-1 expression in patients with esophageal cancer treated with concurrent chemoradiotherapyOncology Letters, 2010
- Cell line cross‐contamination initiative: An interactive reference database of STR profiles covering common cancer cell linesInternational Journal of Cancer, 2009
- Protein Extraction of Formalin-fixed, Paraffin-embedded Tissue Enables Robust Proteomic Profiles by Mass SpectrometryJournal of Histochemistry & Cytochemistry, 2009
- Radiochemotherapy of Esophageal CancerJournal of Thoracic Oncology, 2007
- Biological significance of cancer-associated sialyl-Tn antigen: Modulation of malignant phenotype in gastric carcinoma cellsCancer Letters, 2007
- Expression of sialyl-Tn epitopes on β1 integrin alters epithelial cell phenotype, proliferation and haptotaxisJournal of Cell Science, 2004
- Role of Sialic Acid in the Mobility of Membrane Proteins Containing O‐Linked Oligosaccharides on Polyacrylamide Gel Electrophoresis in Sodium Dodecyl SulfateJBIC Journal of Biological Inorganic Chemistry, 1982